In Brief: FDLI recall process conference
This article was originally published in The Gray Sheet
FDLI recall process conference: Deputy Director of FDA's Division of Emergency and Investigational Operations Ellen Morrison is scheduled to speak March 6 about the agency's policy on domestic and international enforcement trends for medical devices, drugs and biologics at the Food and Drug Law Institute meeting, which will be held at The Madison Hotel in Washington, D.C. Lillian Gill, director of the device center's Office of Compliance, will take part in a panel on "The Role of the Field, Streamlining, and Uniformity between Centers." For more information, call FDLI at 202/371-1420...
You may also be interested in...
Erectile problems prevent a quarter of Brits from being intimate with a partner. Viatris' Upjohn - which markets Viagra Connect in the UK - is working with the Men’s Health Forum, sexual health charity Brook and dating expert Sarah Louise Ryan raise awareness of the problem and get men talking about the issue with their partners and with healthcare professionals.
Medtechs took a long look at themselves as they rose to the challenges of COVID-19. How they responded, repurposed and regrouped to tackle the coronavirus was both sobering and uplifting. The lessons of 2020 must be integrated into the digitally-enabled health care systems of 2021 and beyond.
Top 100 Review: The Calm Before The Storm – But Some Medtechs Already Reflect The Ravages Of COVID-19
2019 saw fewer revenues-boosting major acquisitions by top-tier medtechs. Companies that reported after the calendar year-end were the first to see the consequences of the pandemic on their annual figures.